VON-WILLEBRAND DISEASE IN CHILDHOOD

被引:14
作者
SCHNEPPENHEIM, R
THOMAS, KB
SUTOR, AH
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL, CHILDRENS HOSP, KIEL, GERMANY
[2] UNIV FREIBURG, CHILDRENS HOSP, FREIBURG, GERMANY
关键词
VON WILLEBRAND DISEASE; BLEEDING; VON WILLEBRAND FACTOR; CHILDREN; NEWBORN;
D O I
10.1055/s-2007-1000648
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand disease (vWD), a disorder of primary hemostasis, represents the most frequently inherited bleeding diathesis. It is caused by a quantitative reduction or a qualitative abnormality, or both, of von Willebrand factor (VWF), a glycoprotein normally found in plasma, endothelial cells, subendothelial cell space, megakaryocytes and platelets. Patients with VWD represent a heterogeneous group with different phenotypes and with clinical symptoms that vary in severity. Many of the described types and subtypes of vWD are caused by mutations and aberrations of the vWF gene. The aim of this article is to highlight the impact of gene analysis on the current knowledge of the inheritance of VWD as well as on the structure-function relationship of VWF, and to focus on the available diagnostic laboratory tests and treatment options for patients with VWD, especially in childhood.
引用
收藏
页码:261 / 275
页数:15
相关论文
共 50 条
  • [41] Oligosaccharide structures of von Willebrand factor and their potential robe in von Willebrand disease
    Millar, CM
    Brown, SA
    BLOOD REVIEWS, 2006, 20 (02) : 83 - 92
  • [42] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [43] Current issues in diagnosis and treatment of von Willebrand disease
    Keesler, Daniel A.
    Flood, Veronica H.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (01) : 34 - 41
  • [44] PATIENTS WITH SEVERE VON-WILLEBRAND DISEASE ARE INSENSITIVE TO THE RELEASING EFFECT OF DDAVP - EVIDENCE THAT THE DDAVP-INDUCED INCREASE IN PLASMA FACTOR-VIII IS NOT SECONDARY TO THE INCREASE IN PLASMA VON-WILLEBRAND-FACTOR
    CATTANEO, M
    SIMONI, L
    GRINGERI, A
    MANNUCCI, PM
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) : 333 - 337
  • [45] Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease
    Shihong, I.
    Morris, D.
    Konkle, B. A.
    HAEMOPHILIA, 2009, 15 (01) : 131 - 134
  • [46] CHARACTERIZATION OF 2 CASES OF ACQUIRED TRANSITORY VON-WILLEBRAND SYNDROME WITH CIPROFLOXACIN - EVIDENCE FOR HEIGHTENED PROTEOLYSIS OF VON-WILLEBRAND-FACTOR
    CASTAMAN, G
    LATTUADA, A
    MANNUCCI, PM
    RODEGHIERO, F
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (01) : 83 - 86
  • [47] Optimizing therapy with factor VIII von Willebrand factor concentrates in von Willebrand disease
    Federici, AB
    Mannucci, PM
    HAEMOPHILIA, 1998, 4 : 7 - 10
  • [48] Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency
    Chen, CI
    Federici, AB
    Cramer, EM
    Canciani, MT
    Harrison, P
    Zheng, SL
    Massé, JM
    Mannucci, PM
    Hayward, CPM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) : 20 - 28
  • [49] Study of human von Willebrand factor immunogenicity in pigs with severe von Willebrand disease
    Sauger, A
    Chtourou, S
    Samor, B
    Bonneau, M
    Roussi, J
    Drouet, L
    Mazurier, C
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (03) : 187 - 192
  • [50] Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    WIENER KLINISCHE WOCHENSCHRIFT, 1999, 111 (05) : 181 - 191